Diabetes PubMed

  • Increase font size
  • Default font size
  • Decrease font size
Home Medication Insulin Subcutaneous Use of the Site of Subcutaneous Insulin Administration for the Measurement of Glucose in Patients with Type 1 Diabetes

Use of the Site of Subcutaneous Insulin Administration for the Measurement of Glucose in Patients with Type 1 Diabetes

Diabetes Care. 2010 Mar;33(3):595-601.

Lindpointner S, Korsatko S, Köhler G, Köhler H, Schaller R, Kaidar R, Yodfat O, Schaupp L, Ellmerer M, Pieber TR, Regittnig W.

Department of Internal Medicine, Division of Endocrinology and Nuclear Medicine, Medical University of Graz, Auenbruggerplatz 15, A-8036, Graz, Austria.

Objective - In order to simplify and improve the treatment of patients with type 1 diabetes, we ascertained whether the site of subcutaneous insulin infusion can be used for the measurement of glucose. Research design and methods - Three special indwelling catheters (24-gauge microperfusion (MP) catheters) were inserted into the subcutaneous adipose tissue of subjects with type 1 diabetes (n=10; all C-peptide negative). One MP catheter was perfused with short-acting insulin (100 U/ml, Aspart), and used for insulin delivery and simultaneous glucose sampling during an overnight fast and after ingestion of a standard glucose load (75g). As controls, the further two MP catheters were perfused with an insulin-free solution (5%-mannitol), and used for glucose sampling only. Plasma glucose was measured frequently at the bedside. Results - Insulin delivery with the MP catheter was adequate to achieve and maintain normoglycemia during fasting and after glucose ingestion. Tissue glucose concentrations derived with the insulin-perfused catheter agreed well with plasma glucose levels. Median correlation coefficient and median absolute relative difference values were found to be 0.93 (interquartile range: 0.91-0.97) and 10.9%, respectively. Error grid analysis indicated that the percentage number of tissue values falling in the clinically acceptable range is 99.6%. Comparable analysis results were obtained for the two mannitol-perfused catheters. Conclusions - Our data suggest that estimation of plasma glucose concentrations from the glucose levels directly observed at the site of subcutaneous insulin infusion is feasible and its quality is comparable to that of estimating plasma glucose concentrations from glucose levels measured in insulin-unexposed subcutaneous tissue.

PMID: 20040654

 

Bookmark and Share

Popular Diabetes PubMed Citations

Newsflash

Millions unite for diabetes awareness on World Diabetes Day 2010
Starting today, people from all corners of the world are uniting together for three days of celebration to put diabetes firmly in the public spotlight. World Diabetes Day is the best opportunity there is to draw attention to the silent killer that is diabetes.
 
Bristol-Myers Squibb Foundation Launches $100 Million Initiative
The Bristol-Myers Squibb Foundation announced Together on Diabetes®: Communities Uniting to Meet America's Diabetes Challenge, a 5-year, $100 million initiative to help patients living with type 2 diabetes better manage their disease beyond the doors of their doctor's office - in their homes and communities - and for the course of their disease.
 
New global survey reveals more than one in three patients fail to take insulin as prescribed
More than one in three diabetes patients skip doses or fail to take their insulin as prescribed, stating that they have done so on average three times in the last month, and 77% of physicians estimate that in reality this number could be as high as six doses*, according to the Global Attitudes of Patients and Physicians in Insulin Therapy (GAPPTM) survey, released today by Novo Nordisk.
 

Facebook Page Twitter Subscribe to Latest Diabetes PubMed facts... by Email RSS

Subscribe

Get Diabetes PubMed facts delivered by email. Enter your email address:


Delivered by FeedBurner

Who's Online

We have 6 guests online

Sponsored Links

PharmaNews.eu
PharmaNews.eu - the dynamic European pharmaceutical news engine.
www.pharmanews.eu

Advertise here